Understanding Symptom Recognition and Treatment Decision-making in Hispanic/Latino Lung Cancer Patients
1 other identifier
observational
25
1 country
1
Brief Summary
The purpose of the study is to understand why Hispanic/Latino patients with lung cancer are diagnosed later than other groups.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Nov 2011
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2011
CompletedFirst Submitted
Initial submission to the registry
November 4, 2011
CompletedFirst Posted
Study publicly available on registry
November 8, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2016
CompletedFebruary 11, 2016
February 1, 2016
4.3 years
November 4, 2011
February 10, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
psychosocial issues
related to lung cancer symptom recognition, delays in lung cancer diagnosis of Hispanic/Latino patients and treatment decision-making processes.
2 years
cultural issues
related to lung cancer symptom recognition, delays in lung cancer diagnosis of Hispanic/Latino patients and treatment decision-making processes.
2 years
Secondary Outcomes (1)
identify obstacles
2 years
Study Arms (1)
semi-structured interviews
A qualitative study of MSKCC lung cancer patients of Hispanic/Latino descent by collecting retrospective patient narratives to understand the processes that led them to seek medical help when they did, their experiences in seeking and receiving medical guidance, as well as their decisions regarding lung cancer treatment. In addition, we will explore how these patients' representations of lung cancer with its associated risk factors and symptoms affected their treatment decisions.
Interventions
Use semi-structured interview methods to gather narrative data from research participants, as more open-ended interviews allow participants to share information that is most relevant to their own experiences (Patton, 2002; Rubin \& Rubin, 2005; Kvale, 1996). Semi-structured interviewing can generate a rich understanding of a participant's life routines, experiences, and attitudes related to a topic of inquiry, and can yield a nuanced and thorough description of a research participant's life story and belief systems.
Eligibility Criteria
Self-identified Hispanic/Latino patients with biopsy-proven primary lung cancer treated at MSKCC.
You may qualify if:
- Self-identified Hispanic/Latino patients with biopsy-proven primary lung cancer treated at MSKCC, including stages of disease I-IV
- years of age or older
- Fluent in English or Spanish
- Patients must reside in the U.S
You may not qualify if:
- Spanish-surnamed patients who do not self identify as Hispanic/Latino (e.g., Philippines-born individuals)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
William Alago, MD
Memorial Sloan Kettering Cancer Center
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 4, 2011
First Posted
November 8, 2011
Study Start
November 1, 2011
Primary Completion
February 1, 2016
Study Completion
February 1, 2016
Last Updated
February 11, 2016
Record last verified: 2016-02